| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9362729 | Otolaryngology - Head and Neck Surgery | 2005 | 10 Pages |
Abstract
These preclinical studies provide evidence that an allogenic tumor-dendritic cell fusion vaccine is a valid approach for head and neck cancer immunotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Walter T. MD, Keiji MD, Hide MD, Hiro MD, Jorgen PhD, Suyu PhD,